Breakthrough Stem Cell Transplant Offers Insulin Independence for Type 1 Diabetes Patient

Tagrisso Gains FDA Approval for Treatment of Unresectable Stage III EGFR-Mutated Lung Cancer in the US

Tempus and Takeda Expand Partnership to Enhance Cancer Drug Development with Real-World Data

MedGenome and Twist Bioscience Partner to Launch HOPE for Rare Diseases Programme in India

Bioserve Biotechnologies Unveils PreciOnc: Revolutionizing At-Home Genetic Testing for Cancer Risk

Trinity Biotech Expands Maternal Health Portfolio with Acquisition of Metabolomics Diagnostics

Cepheid and Fleming Initiative Join Forces to Combat Antimicrobial Resistance

Qure.ai, Global Healthcare AI Leader, Raises $65 Million in Series D Funding Led by Lightspeed and 360 ONE Asset

CENTOGENE Unveils Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology

AmoyDx Pan Lung Cancer PCR Panel Approved as Companion Diagnostic for Repotrectinib in Advanced NSCLC

Lilly's Kisunla™ (donanemab-azbt) Gains Approval in Japan for Early Symptomatic Alzheimer's Disease Treatment

Roche Launches 12-Virus Diagnostic Test Across Europe

Government to Launch Program to Develop 12 Indigenous Drugs Targeting 8 Rare Diseases

GRM Information Management and HistoWiz Expand Partnership with HistoWiz Joining GRM as a Client

AstraZeneca India Receives CDSCO Approval for Expanded Indications of Its Chemotherapy Drug